Synthesis and evaluation of novel 4-substituted styryl quinazolines as potential antimicrobial agents. 2012

Rahul P Modh, and Amit C Patel, and Dharmesh H Mahajan, and Christophe Pannecouque, and Erik De Clercq, and Kishor H Chikhalia
Department of Chemistry, Gujarat University, Ahmedabad 380009, Gujarat, India. rahulmodh@gmail.com

In an attempt to afford possible antibacterial and anti-human immunodeficiency virus (HIV) agents, a series of 22 novel styryl quinazoline-based heterocyclic entities were designed and synthesized. Various substituted aryl urea and thiourea cores were incorporated at position 4 of quinazoline, followed by styrylation of position 2, aiming at an augmented biological potential. The synthesized compounds were well characterized through IR, (1) H NMR, (13) C NMR and elemental analyses. All compounds were screened for their in vitro anti-HIV activity against the HIV-1 (IIIB) and HIV-2 (ROD) strains. The antibacterial activity was also evaluated against various pathogenic Gram-positive and Gram-negative bacterial strains.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011799 Quinazolines A group of aromatic heterocyclic compounds that contain a bicyclic structure with two fused six-membered aromatic rings, a benzene ring and a pyrimidine ring. Quinazoline
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006094 Gram-Positive Bacteria Bacteria which retain the crystal violet stain when treated by Gram's method. Gram Positive Bacteria
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015498 HIV-2 An HIV species related to HIV-1 but carrying different antigenic components and with differing nucleic acid composition. It shares serologic reactivity and sequence homology with the simian Lentivirus SIMIAN IMMUNODEFICIENCY VIRUS and infects only T4-lymphocytes expressing the CD4 phenotypic marker. HTLV-IV,Human T-Lymphotropic Virus Type IV,Human immunodeficiency virus 2,LAV-2,HIV-II,Human Immunodeficiency Virus Type 2,Human T Lymphotropic Virus Type IV,Immunodeficiency Virus Type 2, Human,SBL-6669
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

Rahul P Modh, and Amit C Patel, and Dharmesh H Mahajan, and Christophe Pannecouque, and Erik De Clercq, and Kishor H Chikhalia
April 1990, Farmaco (Societa chimica italiana : 1989),
Rahul P Modh, and Amit C Patel, and Dharmesh H Mahajan, and Christophe Pannecouque, and Erik De Clercq, and Kishor H Chikhalia
November 1973, Journal of medicinal chemistry,
Rahul P Modh, and Amit C Patel, and Dharmesh H Mahajan, and Christophe Pannecouque, and Erik De Clercq, and Kishor H Chikhalia
May 2014, European journal of medicinal chemistry,
Rahul P Modh, and Amit C Patel, and Dharmesh H Mahajan, and Christophe Pannecouque, and Erik De Clercq, and Kishor H Chikhalia
December 2013, Molecules (Basel, Switzerland),
Rahul P Modh, and Amit C Patel, and Dharmesh H Mahajan, and Christophe Pannecouque, and Erik De Clercq, and Kishor H Chikhalia
August 1984, Journal of pharmaceutical sciences,
Rahul P Modh, and Amit C Patel, and Dharmesh H Mahajan, and Christophe Pannecouque, and Erik De Clercq, and Kishor H Chikhalia
September 2012, Yao xue xue bao = Acta pharmaceutica Sinica,
Rahul P Modh, and Amit C Patel, and Dharmesh H Mahajan, and Christophe Pannecouque, and Erik De Clercq, and Kishor H Chikhalia
June 2023, ChemMedChem,
Rahul P Modh, and Amit C Patel, and Dharmesh H Mahajan, and Christophe Pannecouque, and Erik De Clercq, and Kishor H Chikhalia
May 2013, European journal of medicinal chemistry,
Rahul P Modh, and Amit C Patel, and Dharmesh H Mahajan, and Christophe Pannecouque, and Erik De Clercq, and Kishor H Chikhalia
September 2009, Archiv der Pharmazie,
Rahul P Modh, and Amit C Patel, and Dharmesh H Mahajan, and Christophe Pannecouque, and Erik De Clercq, and Kishor H Chikhalia
August 2013, Organic and medicinal chemistry letters,
Copied contents to your clipboard!